Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers

NCT01163487 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Head and Neck Cancers

Interventions

DRUG: Dichloroacetate
DEVICE: EF5

Sponsor

Daniel T. Chang